In 41 patients treated with ipilimumab, 34.1% developed cutaneous adverse events that included rash (7.3%), folliculitis (7.3%), mucositis (2.4%), rosacea (2.4%), eczema (2.4%), acneiform eruption (2.4%), syringometaplasia mucinosa (2.4%;), Stevens-Johnson syndrome (2.4%), and vitiligo (4.9%)
However, this shows promise for the future and could be a preventative measure in the meantime
Like any other medical treatment, checking with a professional is an integral part of the overall process
7.27 0.73, p- value : 0.049), mean corpuscular volume (MCH) (27.75 2.45 vs
Depending on the size and location of the tumor, and the overall health of the patient, other treatment options include Mohs surgery, radiation therapy, chemotherapy and immunotherapy